Table 3.
Patients’ baseline characteristics by mortality.
| Characteristics | Alive (n = 34) | Died (n = 18) | p |
|---|---|---|---|
| Age, years | 68±9.8 | 71.3±9.9 | 0.30 |
| Men | 25 (61) | 16 (39) | 0.29 |
| Smoking history | |||
| Current | 4 (66.7) | 2 (33.3) | 0.10 |
| Ex-smoker | 8 (41.1) | 9 (52.9) | 0.14 |
| None | 22 (75.9) | 7 (24.1) | 0.13 |
| Comorbidities | 16 (66.7) | 8 (33.3) | 0.34 |
| FVC, % pred | 80.9±12.2 | 73.1±14.4 | 0.29 |
| Antifibrotic treatment | 33 (70) | 14 (30) | 0.059 |
| Prednisone | 9 (69.2) | 4 (30.8) | 1.00 |
| LTOT | 16 (57.1) | 12 (42.9) | 0.14 |
| Antibiotics | 4 (50) | 4 (50) | 0.42 |
| Inhaled therapy | 8 (61.5) | 5 (38.5) | 0.74 |
| Anticoagulation | 4 (44.4) | 5 (55.6) | 0.13 |
| Referral to transplantation | 9 (81.8) | 2 (18.2) | 0.28 |
*Values are expressed as mean±standard deviation or number (percentage).
*Any treatment was taken into account from the moment of inclusion.
FVC, forced vital capacity; FEV1, forced expiratory volume in the first second; LTOT, long-term oxygen therapy; pred., predicted.